What is considered during the assessment of risk for handling hazardous drugs?

The assessment of risk for handling hazardous drugs (HD) primarily focuses on understanding the specific characteristics of the drug, including its type, dosage form, and the risk of exposure associated with it. This comprehensive evaluation is crucial because the nature of the hazardous drug determines the appropriate safety measures and precautions that must be implemented during handling.

For instance, different HDs possess varying levels of toxicity, routes of exposure, and potential health impacts. By considering the type of drug, one can ascertain whether it is a carcinogen, teratogen, or has other hazardous properties, thereby influencing how it should be handled in a clinical or pharmaceutical setting. The dosage form also plays a significant role; for example, a liquid formulation may present more risk of inhalation or dermal exposure compared to a tablet.

Ultimately, a thorough risk assessment aids in establishing robust safety protocols to protect healthcare workers and patients from potential harm associated with hazardous drug handling. This understanding allows facilities to tailor their processes and practices specifically to the drugs they manage, ensuring compliance with USP <800> standards.